#Sweden #Gothenburg #Zinzino #Zurvita #BalanceOil

Zinzino AB Year-End Report 2025

Zinzino AB has recently released its year-end report for 2025, showcasing remarkable financial performance and strategic acquisitions. The company's revenue for the fourth quarter reached SEK 1,035.3 million, a considerable increase from SEK 713.5 million in the previous year, representing a 45% growth (35%) year-over-year. When adjusted for local currencies, the revenue leap is even more impressive, showing a 52% rise compared to the same period last year.

One of the main factors contributing to this growth is the company's strengthened gross profit, which amounted to SEK 370.3 million, offering a gross profit margin of 35.8%—up from 30.6% during the same quarter last year. Additionally, the report highlights an improvement in EBITDA, with figures rising to SEK 175.2 million, corresponding to an EBITDA margin increase to 16.9% from 10.2% in the previous year. This growth is attributed largely to successful synergies achieved, particularly after Zinzino's acquisition of Zurvita.

Throughout the year, Zinzino has engaged in several strategic initiatives. Notably, the company acquired 35% of Xion International Group, which specializes in algae production utilizing bioreactors. This acquisition is pivotal for the company, as it aims to secure a sustainable supply of omega-3 for its flagship product, BalanceOil. Furthermore, Zinzino has also broadened its market reach by acquiring the assets of the direct sales company Sanki, aimed at augmenting distribution capabilities across North and South America. As part of its innovative offerings, Zinzino launched the Gut Health Test, which is set to enhance its product portfolio for health-conscious consumers.

For the full fiscal year of 2025, Zinzino reported total revenue of SEK 3,337.5 million, indicating a staggering growth of 51% compared to the SEK 2,207.8 million reported in 2024. The full-year EBITDA reached SEK 443.4 million, and the EBITDA margin stabilized at 13.3%. This robust financial showing resulted in a net profit of SEK 324.5 million, leading to earnings per share of SEK 9.09.

In light of these positive developments, Zinzino's Board of Directors has proposed a 50% dividend increase to SEK 6.00 per share for the 2025 financial year, which will be presented for approval at the Annual General Meeting on June 2, 2026. This increase from SEK 4.00 is indicative of the company's strong performance and commitment to returning value to its shareholders.

Financial Highlights

1. Q4 Revenue: SEK 1,035.3 million (45% Y-o-Y growth)
2. Q4 Gross Profit: SEK 370.3 million (35.8% margin)
3. Q4 EBITDA: SEK 175.2 million (16.9% margin)
4. Full Year Revenue: SEK 3,337.5 million (51% growth)
5. Net Profit: SEK 324.5 million

Looking ahead, Zinzino continues to pursue growth and expansion strategies, including plans to increase distribution power in North America and Europe through the acquisition of It Works!, a direct selling company. This acquisition is expected to further enhance Zinzino's reach and operational capabilities in these vital markets, paving the way for sustained growth.

Overall, Zinzino AB’s year-end report for 2025 reflects a period of significant achievements and positive momentum, reinforcing the company’s status as a leader in the health and wellness industry. The strong financial results, combined with strategic expansions and innovative product developments, suggest that Zinzino is well-positioned for continued success in the coming years.